Abstract 6188: Evaluating impact and progress in the iCCaRE consortium for Black men’s approach to reducing prostate cancer disparities

Abstract The purpose of the Inclusive Cancer Care Research Equity for Black men (iCCaRE) Consortium is to address prostate cancer disparities impacting Black men through collaborative research, education, and advocacy. This study evaluates the progress of iCCaRE in achieving its core objectives across five pilot projects supported by multi-institutional partners. Specifically, iCCaRE aims to expand research infrastructure, develop culturally tailored interventions using artificial intelligence to address social determinants of health, explore modifiable social-biological factors affecting patient outcomes, and provide extensive research training for underrepresented minority scientists and advocates. Our methodology involved the creation and implementation of a comprehensive data collection tool via Qualtrics to assess activity outcomes across the Consortium. This tool enabled standardized reporting on publications, grants awarded, media reach, community impact, and additional metrics tied to scientific productivity and partnership engagement. Unpublished data collected this year indicate substantial progress, including an increase in collaborative research outputs, expanded access to prostate cancer care resources, and enhanced engagement with both clinical and community-based partners. These findings underscore the Consortium’s effectiveness in fostering scientific collaboration, developing targeted interventions, and creating infrastructure to support sustainable improvements in prostate cancer outcomes for Black men. These accomplishments provide a strong foundation for iCCaRE’s transition into Phase 2, with plans to deepen community engagement, expand research training, and enhance data-driven insights through advanced analytics. Citation Format: Ivey Breland, Ernest Kaninjing, Damian Francis. Evaluating impact and progress in the iCCaRE consortium for Black men’s approach to reducing prostate cancer disparities [abstract]. In: Proceedings of the American Association for Cancer Research Annual Meeting 2025; Part 1 (Regular Abstracts); 2025 Apr 25-30; Chicago, IL. Philadelphia (PA): AACR; Cancer Res 2025;85(8_Suppl_1):Abstract nr 6188.